Business Wire

THALES

29.4.2021 10:02:07 CEST | Business Wire | Press release

Share
As Cyber Attacks Rise, Thales Chooses OVHcloud for Made in France Hosting of Citadel Team Encrypted Messaging Data

To guarantee security and complete control of data, Thales and OVHcloud have joined forces to offer Citadel Team encrypted messaging customers a trusted hosting platform that guarantees the sovereignty of their data. Citadel Team customers' data is encrypted and stored at OVHcloud, via its own datacenters located in France.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210429005027/en/

Cybercriminals are taking advantage of the Covid-19 pandemic to infiltrate enterprise networks through vulnerabilities created by the large numbers of people working from home. With the sharp rise in cyberattacks — there have been four times the number of attacks in 2020 than in 2019 according to ANSSI , France’s national agency for information system security. There has also been a growing demand for greater security on data sharing and communication apps; it is more important than ever for companies and users to protect their information, encrypt their data and suitable hosting solution to control how it is stored.

Thales offers professionals a secure instant messaging service, Citadel Team, which requires users to register with a company email address. Already adopted by over a third of CAC 40 companies, the service includes the encryption system used by 50 NATO countries. It provides the guarantee that a company’s data will not be used or sold to third parties. It also ensures that all data is stored in France and that the organization can easily manage user devices themselves. Based on these guarantees, the Citadel development teams have recently obtained the France Cybersecurity 2021 label *.

Citadel Team’s new partner, OVHcloud, shares the same values ofsecurity, sovereignty and data protection. Hosting Citadel Team data in OVHcloud's data centers in France is a guarantee for customers of the application to benefit from an environment of trust. OVHcloud relies on an integrated model that gives it complete control over its value chain: from the design of its servers to the construction and management of its data centers, not forgetting the orchestration of its fiber optic network.

Available free of charge, Citadel Team offers users end-to-end encrypted messaging and voice services on a smartphone or computer, plus a host of premium services, including videoconferencing, group calls and screen sharing. Citadel Team continues to add new functionality tailored to the communication requirements of professionals to offer an all-in-one communication solution without sacrificing data security or usability. Citadel Team is also a member of the Open Trusted Cloud programme, initiated by OVHcloud to federate an ecosystem of trusted players and solutions that respect data protection laws.

“We are especially proud to announce this partnership to our customers and the general public. Thales and OVH have been trusted partners for many years, and by combining our strengths under this new hosting arrangement, we are taking the sovereign Citadel Team solution to the next level to offer our customers the very best data hosting option available.” Pierre-Yves Jolivet, Vice President, Cyber Defence Solutions, Thales.

« We welcome Thales' choice to host Citadel Team data on OVHcloud infrastructures. The combination of our strengths is good news for users looking for guarantees that their data will be respected. They can now be sure to benefit from an alternative, trusted and secure end-to-end solution.» Caroline Comet-Fraigneau, VP France and Benelux, OVHcloud

* The label «France Cybersecurity », is a guarantee for users that the products and services bearing the label are French and that they have clear and well-defined functionalities, with a level of quality attested by an independent jury.

About Thales
Thales (Euronext Paris: HO) is a global leader in advanced technologies, investing in digital and “deep tech” innovations – connectivity, big data, artificial intelligence, cybersecurity and quantum computing – to build a confident future crucial for the development of our societies. The Group provides its customers – businesses, organisations and governments – in the defense, aeronautics, space, transport, and digital identity and security domains with solutions, services and products that help them fulfil their critical role, consideration for the individual being the driving force behind all decisions.
Thales has 81,000 employees in 68 countries. In 2020 the Group generated sales of €17 billion.

PLEASE VISIT

Thales Group
Defence and Security | Thales Group

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye